About Pharmacoepidemiology

Pharmacoepidemiology is an international, peer-reviewed, open access journal focusing on high-quality epidemiological, clinical research across the fields of clinical pharmacology and epidemiology, published quarterly online by MDPI.

Aims

Pharmacoepidemiology (ISSN 2813-0618) is an international, peer-reviewed, open access journal that publishes original articles, critical reviews, and short communications on high-quality studies across the fields of pharmacoepidemiology, clinical pharmacology, and epidemiology. The aim of Pharmacoepidemiology is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, the journal has no restrictions on the maximum length of the papers. Full experimental details should be provided so that the results can be reproduced.

Scope

Pharmacoepidemiology welcomes manuscripts covering a broad range of areas including, but not limited to, the following:

• Designs, analyses, results, and interpretations of studies on drugs, biologics, or medical devices;
• Molecular pharmacoepidemiology;
• The methodology of pharmacoepidemiology;
• Pharmacovigilance/preventative pharmacovigilance/ecopharmacovigilance;
• Patient safety;
• Pharmacoepidemiology studies in targeted populations and settings;
• Patterns of drug utilization;
• Patterns of drug prescription, appropriateness of prescriptions, overprescription;
• Polypharmacology;
• Randomized control trials on drugs;
• Systematic review or meta-analysis related to drugs;
• Post-marketing surveillance;
• Pharmacoeconomics;
• The formulation and interpretation of regulatory guidelines;
• Studies on the benefits/safety/effectiveness of pharmaceuticals, biologics, or medical devices;
• Harm/benefit assessments in drug therapy;
• The evaluation of risk management plans on pharmaceuticals, biologics, and medical devices.

MDPI Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.

Book Reviews

Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.

MDPI
Grosspeteranlage 5
CH-4052 Basel
Switzerland

Copyright / Open Access

Articles published in Pharmacoepidemiology will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:

Reprints

Reprints may be ordered. Please contact for more information on how to order reprints.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is .

Editorial Office

For further MDPI contacts, see here.